REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior management will participate in the following investor conferences:
- Truist Securities BioPharma Symposium In New York City on Wednesday, November 8, 2023, for 1×1 meetings only.
- UBS Biopharma Conference in Miami on Thursday, November 9, 2023, a fireside chat presentation at 11:30 a.m. Eastern Time will be webcast.
- 6th Annual Evercore ISI HealthCONx Conference in Miami on November 28-30, 2023, a fireside chat presentation on November 30th at 12:30 p.m. Eastern Time will be webcast.
A live audio webcast and an archive of the presentations from UBS Biopharma and Evercore ISI HealthCONx conferences will be available on the investors’ page of the Coherus website at http://investors.coherus.com.
Coherus Contact Information:
Jami Taylor
VP, Investor Relations
IR@coherus.com
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Siili Solutions Plc, Business review, 1 January–31 March 2025 - April 22, 2025
- Düsseldorf-Based Art Collector Andrew Jovic Featured in the BMW Art Guide by Independent Collectors - April 22, 2025
- Start of construction of the fourth stage of the Vilneles Skverai residential project (Vilnius, Lithuania) - April 22, 2025
